Levchenko et al. first reported in 2005 that functional ABCB1 can transfer from drug-resistant to drug-sensitive cancer cells both in vitro and in vivo, resulting in increased drug resistance without the expression of the ABCB1 gene[78]. The gene discussed is ABCB1; the disease is cancer.